Article about Immatics' TCR therapy approach

| USA, News

Benchside TCR therapy insights! Review the interview with Amir Alpert (Senior Scientist) about "Harnessing the Power of the Immune Systeme: Optimizing T Cell Killing Cancer Immunotherapy" in "Select Science". 

Review the full article here.

Press Contact

Dr Nikola Wiegeler

Press contact,
Immatics Biotechnologies GmbH

+49 7071 5397-0

Go back